A Safe and Effective One‐Day Oral Aspirin Challenge for the Diagnosis of Nonsteroidal Anti‐Inflammatory Drug ( NSAID ) Hypersensitivity
Clinical & Experimental Allergy · 10.11.2026
DOI: 10.1111/cea.70475 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical & Experimental Allergy, online erschienen am 10.11.2026. Verfasst von Ching Ching Yung und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Adult Allergy, Guy's and St Thomas' NHS Foundation Trust, London, UK. Die Arbeit nennt 5 Literaturangaben.
Abstract (Originalsprache)
An oral aspirin challenge can safely diagnose different subtypes of NSAID hypersensitivity within a day. Mean cumulative provocative dose should be used for easy comparison between different OAC protocols
Autor:innen und Institutionen
- Department of Adult Allergy, Guy's and St Thomas' NHS Foundation Trust, London, UK.
- School of Immunology and Microbial Sciences, King's College London, London, UK.
- King's Centre for Lung Health, King's College London, London, UK.
ORCID-Profile: Ching Ching Yung, Grzegorz Woszczek, Prathap Pillai
Zitieren
APA
Yung, C. C., Woszczek, G., & Pillai, P. (2026). A Safe and Effective One‐Day Oral Aspirin Challenge for the Diagnosis of Nonsteroidal Anti‐Inflammatory Drug ( NSAID ) Hypersensitivity. Clinical & Experimental Allergy. https://doi.org/10.1111/cea.70475
Vancouver
Yung CC, Woszczek G, Pillai P. A Safe and Effective One‐Day Oral Aspirin Challenge for the Diagnosis of Nonsteroidal Anti‐Inflammatory Drug ( NSAID ) Hypersensitivity. Clinical & Experimental Allergy. 2026. doi:10.1111/cea.70475
BibTeX
@article{Yung2026,
author = {Yung, Ching Ching and Woszczek, Grzegorz and Pillai, Prathap},
title = {A Safe and Effective One‐Day Oral Aspirin Challenge for the Diagnosis of Nonsteroidal Anti‐Inflammatory Drug ( NSAID ) Hypersensitivity},
journal = {Clinical & Experimental Allergy},
year = {2026},
doi = {10.1111/cea.70475}
}
EUVIMED